VVOS

Vivos Therapeutics, Inc.

Price Chart

No historical data available

Latest Quote

$0.22

-0.03 (-12.96%)
Current Price
Previous Close $0.26
Open $0.26
Day High $0.27
Day Low $0.22
Volume 4,619,194
Fetched: 2026-08-31T10:51:08
Stock Information
Shares Outstanding 20.12M
Total Debt $12.51M
Cash Equivalents $1.77M
Revenue $20.90M
Net Income $-25.46M
Sector Healthcare
Industry Medical Devices
Market Cap $4.52M
EPS (TTM) $-1.88
Exchange NCM
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

📰 Latest News
No news articles available at the moment. Check back later for updates on VVOS.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $6,901,000 $6,012,000 $5,530,000 $6,005,000
Cost Of Revenue $6,901,000 $6,012,000 $5,530,000 $6,005,000
Total Revenue $17,443,000 $15,031,000 $13,801,000 $16,024,000
Operating Revenue $17,443,000 $15,031,000 $13,801,000 $16,024,000
Expenses
Total Expenses $37,337,000 $26,202,000 $31,097,000 $41,055,000
Other Income Expense $-1,336,000 $35,000 $3,713,000 $1,186,000
Other Non Operating Income Expenses $-1,336,000 $35,000 $-65,000 $-101,000
Operating Expense $30,436,000 $20,190,000 $25,567,000 $35,050,000
Selling And Marketing Expense $1,400,000 $1,731,000 $2,467,000 $5,340,000
General And Administrative Expense $27,727,000 $17,878,000 $22,479,000 $29,041,000
Interest Expense - - - $0
Net Non Operating Interest Income Expense - - - $0
Interest Expense Non Operating - - - $0
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-21,230,000 $-11,136,000 $-13,583,000 $-23,845,000
Normalized Income $-21,230,000 $-11,136,000 $-17,361,000 $-25,132,000
Net Income From Continuing And Discontinued Operation $-21,230,000 $-11,136,000 $-13,583,000 $-23,845,000
Total Operating Income As Reported $-19,894,000 $-11,171,000 $-17,296,000 $-25,031,000
Net Income Common Stockholders $-21,230,000 $-11,136,000 $-13,583,000 $-23,845,000
Net Income $-21,230,000 $-11,136,000 $-13,583,000 $-23,845,000
Net Income Including Noncontrolling Interests $-21,230,000 $-11,136,000 $-13,583,000 $-23,845,000
Net Income Continuous Operations $-21,230,000 $-11,136,000 $-13,583,000 $-23,845,000
Pretax Income $-21,230,000 $-11,136,000 $-13,583,000 $-23,845,000
Operating Income $-19,894,000 $-11,171,000 $-17,296,000 $-25,031,000
Depreciation Amortization Depletion Income Statement $1,309,000 $581,000 $621,000 $669,000
Depreciation And Amortization In Income Statement $1,309,000 $581,000 $621,000 $669,000
Gross Profit $10,542,000 $9,019,000 $8,271,000 $10,019,000
Special Income Charges - - $0 $1,287,000
Net Interest Income - - - $0
Interest Income - - - -
Interest Income Non Operating - - - -
Per Share
Diluted EPS $-2.07 $-2.22 $-11.14 $-25.90
Basic EPS $-2.07 $-2.22 $-11.14 $-25.90
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-18,585,000 $-10,590,000 $-20,453,000 $-25,649,000
Reconciled Depreciation $1,309,000 $581,000 $621,000 $669,000
EBITDA (Bullshit earnings) $-18,585,000 $-10,590,000 $-16,675,000 $-24,362,000
EBIT $-19,894,000 $-11,171,000 $-17,296,000 $-25,031,000
Diluted Average Shares $10,273,881 $5,019,886 $1,219,381 $920,592
Basic Average Shares $10,273,881 $5,019,886 $1,219,381 $920,592
Diluted NI Availto Com Stockholders $-21,230,000 $-11,136,000 $-13,583,000 $-23,845,000
Selling General And Administration $29,127,000 $19,609,000 $24,946,000 $34,381,000
Other Gand A $27,727,000 $17,878,000 $22,479,000 $29,041,000
Total Unusual Items - - $3,778,000 $1,287,000
Total Unusual Items Excluding Goodwill - - $3,778,000 $1,287,000
Gain On Sale Of Security - - $3,778,000 -
Tax Provision - - - $0
Other Special Charges - - - $-1,287,000
Write Off - - - $0
Otherunder Preferred Stock Dividend - - - -
Fetched: 2026-08-19
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-14,107,000 $4,702,000 $-2,852,000 $1,656,000
Total Assets $25,152,000 $15,284,000 $10,730,000 $13,720,000
Total Non Current Assets $20,768,000 $7,811,000 $8,269,000 $8,296,000
Other Non Current Assets $228,000 $216,000 $307,000 $374,000
Goodwill And Other Intangible Assets $12,617,000 $3,252,000 $3,263,000 $3,145,000
Other Intangible Assets $4,045,000 $409,000 $420,000 $302,000
Current Assets $4,384,000 $7,473,000 $2,461,000 $5,424,000
Other Current Assets $774,000 $783,000 $616,000 $1,448,000
Receivables $1,581,000 $430,000 $202,000 $457,000
Accounts Receivable $1,581,000 $430,000 $202,000 $457,000
Allowance For Doubtful Accounts Receivable $-882,000 $-390,000 $-268,000 $-712,000
Gross Accounts Receivable $2,463,000 $820,000 $470,000 $1,169,000
Cash Cash Equivalents And Short Term Investments $2,029,000 $6,260,000 $1,643,000 $3,519,000
Cash And Cash Equivalents $2,029,000 $6,260,000 $1,643,000 $3,519,000
Non Current Prepaid Assets - - - $374,000
Non Current Note Receivables - - - -
Prepaid Assets - - - -
Other Receivables - - - -
Notes Receivable - - - -
Debt
Net Debt $6,793,000 - - -
Total Debt $13,502,000 $1,512,000 $1,995,000 $2,413,000
Long Term Debt And Capital Lease Obligation $4,422,000 $1,035,000 $1,521,000 $1,994,000
Long Term Debt $469,000 - - -
Current Debt And Capital Lease Obligation $9,080,000 $477,000 $474,000 $419,000
Current Debt $8,353,000 - - -
Other Current Borrowings $8,353,000 - - -
Liabilities
Total Liabilities Net Minority Interest $26,702,000 $7,330,000 $10,319,000 $8,919,000
Total Non Current Liabilities Net Minority Interest $8,626,000 $2,352,000 $3,030,000 $2,106,000
Other Non Current Liabilities $1,300,000 - - -
Non Current Deferred Liabilities $0 $97,000 $289,000 $112,000
Current Liabilities $18,076,000 $4,978,000 $7,289,000 $6,813,000
Other Current Liabilities $850,000 $273,000 $198,000 $145,000
Current Deferred Liabilities $479,000 $896,000 $2,138,000 $2,926,000
Payables And Accrued Expenses $7,667,000 $3,332,000 $4,479,000 $3,323,000
Interest Payable $1,952,000 $0 - -
Payables $2,478,000 $1,579,000 $2,472,000 $1,411,000
Total Tax Payable $799,000 $481,000 $327,000 -
Accounts Payable $1,679,000 $1,098,000 $2,145,000 $1,411,000
Equity
Common Stock Equity $-1,490,000 $7,954,000 $411,000 $4,801,000
Total Equity Gross Minority Interest $-1,550,000 $7,954,000 $411,000 $4,801,000
Stockholders Equity $-1,490,000 $7,954,000 $411,000 $4,801,000
Retained Earnings $-125,357,000 $-104,187,000 $-93,051,000 $-79,468,000
Other
Ordinary Shares Number $9,286,609 $5,889,520 $1,833,877 $920,484
Share Issued $9,286,609 $5,889,520 $1,833,877 $920,484
Tangible Book Value $-14,107,000 $4,702,000 $-2,852,000 $1,656,000
Invested Capital $7,332,000 $7,954,000 $411,000 $4,801,000
Working Capital $-13,692,000 $2,495,000 $-4,828,000 $-1,389,000
Capital Lease Obligations $4,680,000 $1,512,000 $1,995,000 $2,413,000
Total Capitalization $-1,021,000 $7,954,000 $411,000 $4,801,000
Minority Interest $-60,000 $0 - -
Additional Paid In Capital $123,866,000 $112,141,000 $93,462,000 $84,269,000
Capital Stock $1,000 $0 $0 $0
Common Stock $1,000 $0 $0 $0
Preferred Stock $0 $0 $0 $0
Employee Benefits $2,904,000 $1,220,000 $1,220,000 $0
Non Current Deferred Revenue $0 $97,000 $289,000 $112,000
Long Term Capital Lease Obligation $3,953,000 $1,035,000 $1,521,000 $1,994,000
Current Deferred Revenue $479,000 $896,000 $2,138,000 $2,926,000
Current Capital Lease Obligation $727,000 $477,000 $474,000 $419,000
Current Accrued Expenses $5,189,000 $1,753,000 $2,007,000 $1,912,000
Goodwill $8,572,000 $2,843,000 $2,843,000 $2,843,000
Net PPE $7,923,000 $4,343,000 $4,699,000 $4,777,000
Accumulated Depreciation $-2,936,000 $-2,780,000 $-2,326,000 $-1,753,000
Gross PPE $10,859,000 $7,123,000 $7,025,000 $6,530,000
Leases $3,197,000 $2,479,000 $2,479,000 $2,479,000
Construction In Progress $0 $1,857,000 $1,435,000 $948,000
Other Properties $4,572,000 $1,438,000 $1,790,000 $1,838,000
Machinery Furniture Equipment $3,090,000 $1,349,000 $1,321,000 $1,265,000
Properties $0 $0 $0 $0
Dueto Related Parties Current - - - -
Fetched: 2026-08-19
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-17,604,000 $-13,259,000 $-12,749,000 $-20,511,000
Operating Activities
Operating Cash Flow $-15,263,000 $-12,691,000 $-11,946,000 $-19,587,000
Cash Flow From Continuing Operating Activities $-15,263,000 $-12,691,000 $-11,946,000 $-19,587,000
Operating Gains Losses - $31,000 $-3,041,000 $-518,000
Investing Activities
Capital Expenditure $-2,341,000 $-568,000 $-803,000 $-924,000
Investing Cash Flow $-7,526,000 $-568,000 $-853,000 $-924,000
Cash Flow From Continuing Investing Activities $-7,526,000 $-568,000 $-853,000 $-924,000
Net Other Investing Changes - - $-50,000 -
Financing Activities
Issuance Of Capital Stock $5,576,000 $7,796,000 $4,000,000 $0
Financing Cash Flow $18,558,000 $17,876,000 $10,923,000 $0
Cash Flow From Continuing Financing Activities $18,558,000 $17,876,000 $10,923,000 $0
Net Other Financing Charges $-837,000 $-1,361,000 $-1,077,000 -
Net Common Stock Issuance $5,576,000 $7,796,000 $4,000,000 $0
Common Stock Issuance $5,576,000 $7,796,000 $4,000,000 $0
Repurchase Of Capital Stock - - - $0
Net Preferred Stock Issuance - - - $0
Preferred Stock Issuance - - - -
Other
Repayment Of Debt $-28,000 $0 - $0
Issuance Of Debt $10,673,000 $0 - -
Interest Paid Supplemental Data $0 $9,000 $0 $0
End Cash Position $2,029,000 $6,260,000 $1,643,000 $3,519,000
Beginning Cash Position $6,260,000 $1,643,000 $3,519,000 $24,030,000
Changes In Cash $-4,231,000 $4,617,000 $-1,876,000 $-20,511,000
Proceeds From Stock Option Exercised $3,174,000 $11,441,000 $8,000,000 -
Net Issuance Payments Of Debt $10,645,000 $0 - $0
Net Long Term Debt Issuance $10,645,000 $0 - $0
Long Term Debt Payments $-28,000 $0 - $0
Long Term Debt Issuance $10,673,000 $0 - -
Net Business Purchase And Sale $-5,185,000 $0 - $0
Purchase Of Business $-5,185,000 $0 - $0
Net PPE Purchase And Sale $-2,341,000 $-568,000 $-803,000 $-924,000
Purchase Of PPE $-2,341,000 $-568,000 $-803,000 $-924,000
Change In Working Capital $3,997,000 $-2,940,000 $2,864,000 $1,711,000
Change In Other Working Capital $-514,000 $-1,434,000 $-611,000 $1,154,000
Change In Other Current Liabilities $538,000 $-129,000 $1,152,000 $151,000
Change In Payables And Accrued Expense $4,142,000 $-1,087,000 $1,156,000 $-450,000
Change In Accrued Expense $3,618,000 $-39,000 $422,000 $-941,000
Change In Payable $524,000 $-1,048,000 $734,000 $491,000
Change In Account Payable $524,000 $-1,048,000 $734,000 $491,000
Change In Prepaid Assets $48,000 $-62,000 $912,000 $110,000
Change In Receivables $-217,000 $-228,000 $255,000 $746,000
Changes In Account Receivables $-217,000 $-228,000 $255,000 $746,000
Stock Based Compensation $661,000 $762,000 $1,106,000 $2,396,000
Depreciation Amortization Depletion $1,309,000 $581,000 $621,000 $669,000
Depreciation And Amortization $1,309,000 $581,000 $621,000 $669,000
Net Income From Continuing Operations $-21,230,000 $-11,136,000 $-13,583,000 $-23,845,000
Other Non Cash Items - $11,000 $87,000 -
Gain Loss On Investment Securities - $31,000 $-3,041,000 $711,000
Preferred Stock Payments - - - $0
Asset Impairment Charge - - - $0
Income Tax Paid Supplemental Data - - - -
Fetched: 2026-08-19